MY202113A - Enterovirus 71 animal model - Google Patents
Enterovirus 71 animal modelInfo
- Publication number
- MY202113A MY202113A MYPI2017001107A MYPI2017001107A MY202113A MY 202113 A MY202113 A MY 202113A MY PI2017001107 A MYPI2017001107 A MY PI2017001107A MY PI2017001107 A MYPI2017001107 A MY PI2017001107A MY 202113 A MY202113 A MY 202113A
- Authority
- MY
- Malaysia
- Prior art keywords
- enterovirus
- animal model
- relates
- present
- vpl
- Prior art date
Links
- 241001529459 Enterovirus A71 Species 0.000 title abstract 5
- 238000010171 animal model Methods 0.000 title abstract 2
- 241000283984 Rodentia Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32371—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Food Science & Technology (AREA)
Abstract
The present invention relates to Enterovirus 71 (EV71), the development of an animal model and screening of candidate anti-EV71 compounds. More specifically, the present invention relates to the discovery that Enterovirus 71 (EV71) strains that have been adapted to infect rodent cell lines or cloned derived virus containing mutations in VPl can cause disease in immuno-competent rodents.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562108828P | 2015-01-28 | 2015-01-28 | |
| US201562114880P | 2015-02-11 | 2015-02-11 | |
| PCT/SG2016/050031 WO2016122403A1 (en) | 2015-01-28 | 2016-01-25 | Enterovirus 71 animal model |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY202113A true MY202113A (en) | 2024-04-04 |
Family
ID=56543857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2017001107A MY202113A (en) | 2015-01-28 | 2016-01-25 | Enterovirus 71 animal model |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JP6772155B2 (en) |
| KR (1) | KR20170106473A (en) |
| CN (1) | CN107849540B (en) |
| AU (1) | AU2016212766B2 (en) |
| MY (1) | MY202113A (en) |
| SG (1) | SG11201706054QA (en) |
| TW (1) | TWI764859B (en) |
| WO (1) | WO2016122403A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112094822B (en) * | 2019-06-02 | 2025-10-24 | 复旦大学 | Infectious cDNA cloning based on EV71 strain and its application |
| KR102243526B1 (en) * | 2020-01-21 | 2021-04-22 | (주)노터스생명과학 | Transgenic animal for Nonclinical evaluation of Foot and Mouth Disease Vaccine and producing method thereof |
| US20240043944A1 (en) * | 2020-12-21 | 2024-02-08 | Chiaho Shih | Novel enterovirus 71 mutations associated with disease severity |
| CN114304064A (en) * | 2021-12-16 | 2022-04-12 | 首都医科大学 | Method for establishing animal model with head deformity accompanied with nerve-dyskinesia |
| CN115211402A (en) * | 2022-07-07 | 2022-10-21 | 中国医学科学院医学生物学研究所 | Construction method and use of a rodent model of CV-B3 infection |
| CN117143204B (en) * | 2023-08-04 | 2025-11-21 | 中国医学科学院医药生物技术研究所 | Construction and application of enterovirus 71 type VP1 protein 75 th amino acid mutant virus strain |
| CN119842818A (en) * | 2025-03-19 | 2025-04-18 | 中国医学科学院医学生物学研究所 | Mouse model for infecting coxsackievirus A16 and construction method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102220288B (en) * | 2011-05-04 | 2013-07-17 | 中国科学院上海巴斯德研究所 | Mouse-addapted enterovirus EV71 strain 573 and use thereof |
-
2016
- 2016-01-25 WO PCT/SG2016/050031 patent/WO2016122403A1/en not_active Ceased
- 2016-01-25 CN CN201680019293.5A patent/CN107849540B/en active Active
- 2016-01-25 SG SG11201706054QA patent/SG11201706054QA/en unknown
- 2016-01-25 KR KR1020177023889A patent/KR20170106473A/en not_active Ceased
- 2016-01-25 AU AU2016212766A patent/AU2016212766B2/en active Active
- 2016-01-25 JP JP2017540259A patent/JP6772155B2/en active Active
- 2016-01-25 MY MYPI2017001107A patent/MY202113A/en unknown
- 2016-01-27 TW TW105102566A patent/TWI764859B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP6772155B2 (en) | 2020-10-21 |
| AU2016212766A1 (en) | 2017-09-07 |
| JP2018513671A (en) | 2018-05-31 |
| NZ734517A (en) | 2024-12-20 |
| CN107849540B (en) | 2021-12-21 |
| AU2016212766B2 (en) | 2022-03-24 |
| WO2016122403A1 (en) | 2016-08-04 |
| KR20170106473A (en) | 2017-09-20 |
| CN107849540A (en) | 2018-03-27 |
| TW201702376A (en) | 2017-01-16 |
| TWI764859B (en) | 2022-05-21 |
| SG11201706054QA (en) | 2017-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY202113A (en) | Enterovirus 71 animal model | |
| CY1125424T1 (en) | NON-HUMAN ANIMALS EXPRESSING HUMANIZED CD3 COMPLEX | |
| MX2022001202A (en) | MICE WITH HUMANIZED SIRP¿-IL15 GENES INSERTED AND METHODS TO USE THEM. | |
| Redinbaugh et al. | Control of virus diseases in maize | |
| EP3801568A4 (en) | GENOME EDITED INVARIANT NATURAL KILLER T CELLS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNITIES | |
| MX383596B (en) | BISPECIFIC MOLECULES THAT ARE IMMUNOREEACTIVE WITH IMMUNE EFFECTOR CELLS THAT EXPRESS AN ACTIVATING RECEPTOR AND AN ANTIGEN EXPRESSED BY A VIRUS-INFECTED CELL AND THEIR USES. | |
| GB2548059A (en) | Induced hepatocytes and uses thereof | |
| EA201792663A1 (en) | METHODS OF SCREENING BACTERIA, ARCHEAN, ALGAE AND YEAST WITH THE USE OF CRISPR NUCLEIC ACIDS | |
| HUE053717T2 (en) | Process for the comprehensive processing of lignite and leonardite into humus fertilizers, preparations and fuel briquettes | |
| ZA202204981B (en) | Synthetic chimeric poxviruses | |
| IL270876A (en) | Novel oncolytic viruses for inducing tumor cell killing by natural killer cells | |
| MX2020011586A (en) | Synthetic chimeric vaccinia virus. | |
| WO2017048809A8 (en) | Nk cells exhibiting an adaptive phenotype and methods for preparing and for using | |
| EA201791416A1 (en) | POPULATION OF RPE CELLS AND METHODS TO OBTAIN THEM | |
| EA201691677A1 (en) | GENETIC LOCUSES ASSOCIATED WITH INCREASED FERTILITY IN MAIS | |
| MX390053B (en) | GENOMIC EVALUATION METHODS IN LIVESTOCK. | |
| Liu et al. | Diamond-α weighted Ostrowski type and Grüss type inequalities on time scales | |
| Aggarwal | Correlation functions of the Schur process through Macdonald difference operators | |
| FR3030523B1 (en) | NOVEL COMPOUNDS OF THE N-ACYLAMINO-AMIDE FAMILY, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF | |
| Jia et al. | Spatial pattern in an ecosystem of phytoplankton–nutrient from remote sensing | |
| EA201591444A1 (en) | MUTED ALLENOXIDE SYNTHASE 2 GENES (AOS2) | |
| Полетаев et al. | The potential of educational migration to professional education organizations in the context of the new migration policy | |
| Gojdičová et al. | Draft list of invasive alien species of the Carpathian Region | |
| GB2565957A (en) | Novel renal disease model | |
| Kalla et al. | ASSESSMENT OFTHE VIABILITY OF THE COCCOID FORM OF HELICOBACTER PYLORI IN MICE |